PyInvesting

Market research

GU5.F Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

F EUR Healthcare

Latest close

1.41 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
2B
P/E ratio
8.29
Analyst target
Not available
Dividend yield
52.%
Beta
0.18

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is currently in a long term uptrend where the price is trading 15.4% above its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.4.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's total revenue sank by 0.7% to $15B since the same quarter in the previous year.

Its net income has increased by 772.4% to $256M since the same quarter in the previous year.

Finally, its free cash flow fell by 104.2% to $-153M since the same quarter in the previous year.

Based on the above factors, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited gets an overall score of 3/5.